Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lybrido pharmacokinetic crossover study in healthy premenopausal women
NL-OMON36050Active, not recruiting
- Sponsor
- Emotional Brain
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of testosterone and sildenafil in hypoactive sexual desire disorder (HSDD) and female sexual dysfunction (FSD) (2 arms), sponsored by Emotional Brain. Primary endpoints: Cmax of total testosterone, Cmax of free testosterone and 4 more. Started May 2011; status: active, not recruiting.
02
Drugs
testosteronesildenafil
03
Conditions
hypoactive sexual desire disorder (HSDD)female sexual dysfunction (FSD)
Beyond the preview
Go deeper on NL-OMON36050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36050.